Photo of Christopher D. Adams

Chair, Criminal Defense & Regulatory Compliance Practice Group

Mr. Adams concentrates his practice in the areas of criminal defense, internal investigations, attorney ethics matters and disciplinary proceedings, and complex commercial litigation. With a national practice that has encompassed the representation of high profile individuals, Mr. Adams has served as counsel to professional athletes, elected officials and candidates for public office, political campaigns, and numerous public and private business entities.

In the healthcare sector, Mr. Adams has successfully defended physicians charged with crimes in federal and state court, as well as in front of the Board of Medical Examiners (BME). He has negotiated the relicensure of physicians whose licenses were revoked by the BME and assisted in the development of re-entry plans in conjunction with the BME and the Office of the Attorney General. In addition, he has defended physicians in Medicare debarment proceedings and negotiated their re-entry into the Medicare program.

With a demonstrated track record of success in taking on difficult matters, Mr. Adams has tried cases in state and federal courts throughout the country. His experience includes appearances before the U.S. District Courts for the District of New Jersey, Northern District of California, Middle District of Florida, Northern District of Illinois, District of South Dakota, and the U.S. Court of Appeals for the Third Circuit. He has argued significant matters before the New Jersey Supreme Court and Appellate Division, and before other state courts including those in Florida and Alabama.

Contact information: | 732.476.2692 | vCard  | LinkedIn

For more information visit the Greenbaum, Rowe, Smith & Davis LLP website.

A recent holding by the Eighth Circuit Court of Appeals in United States ex rel. Cairns v. D.S. Med., LLC took a stance on the causation standard for False Claims Act (FCA) cases premised on violations of the Anti-Kickback Statute (AKS) and may provide defendants in those cases with the ability to raise a valid

More than a year has passed since U.S. Attorney General Merrick B. Garland established the COVID-19 Fraud Enforcement Task Force to utilize the resources of the U.S. Department of Justice (DOJ) and partner with various governmental agencies to combat COVID-19-related fraud. Since that time, the DOJ has touted its enforcement efforts in both the civil

The COVID-19 Fraud Enforcement Task Force was established in May 2021 to utilize the resources of the U.S. Department of Justice (DOJ) and various governmental agencies to combat COVID-19-related fraud. These efforts have led to investigations and prosecutions involving Paycheck Protection Program (PPP) fraud as well as healthcare-related COVID-19 fraud, the extent, and implications of